Lung cancer is the leading cause of cancer-related death globally — and India faces a particularly complex burden. While smoking remains the dominant risk factor, a significant proportion of lung cancer cases in India occur in non-smokers, suggesting that genetic susceptibility plays a more prominent role than in Western populations. Understanding the genetic basis of lung cancer susceptibility in India is critical for developing targeted prevention and early detection strategies.
The Indian Lung Cancer Landscape
India accounts for approximately 6.9% of global lung cancer cases, with an estimated 72,000 new cases annually. Notably, lung cancer in India has several distinctive features compared to Western populations: a higher proportion of cases in non-smokers (particularly women), a higher prevalence of adenocarcinoma (the most common subtype in non-smokers), and a higher frequency of EGFR mutations (found in 30–40% of Indian NSCLC patients vs. 10–15% in Western patients).
Genetic Risk Factors for Lung Cancer
Inherited Susceptibility Variants
Genome-wide association studies (GWAS) have identified several chromosomal regions associated with lung cancer susceptibility. Key loci include:
- 15q25 (CHRNA5-CHRNA3-CHRNB4): Nicotinic acetylcholine receptor genes. Variants in this region are associated with both smoking behavior and lung cancer risk independent of smoking.
- 5p15 (TERT-CLPTM1L): Telomerase reverse transcriptase gene. Variants associated with lung cancer risk across multiple populations.
- 6p21 (HLA region): Immune function genes. Variants associated with lung cancer susceptibility.
Carcinogen Metabolism Genes
Genes encoding enzymes that metabolize tobacco carcinogens influence individual susceptibility to smoking-related lung cancer. Key genes include CYP1A1, CYP1B1, GSTM1, and GSTT1. Variants that increase carcinogen activation or reduce detoxification increase lung cancer risk in smokers.
DNA Repair Genes
Variants in DNA repair genes (ERCC1, ERCC2, XRCC1) affect the ability to repair DNA damage caused by carcinogens — influencing both cancer susceptibility and response to platinum-based chemotherapy.
Somatic Mutations Driving Lung Cancer in India
Beyond inherited susceptibility, the somatic mutations driving lung cancer in Indian patients differ from Western populations. EGFR mutations are found in 30–40% of Indian NSCLC patients — making EGFR-targeted therapy (erlotinib, gefitinib, osimertinib) particularly relevant. ALK rearrangements occur in approximately 5–7% of cases. KRAS mutations, common in Western lung cancer, are less frequent in Indian patients.
Implications for Prevention and Early Detection
Understanding genetic susceptibility allows for targeted screening of high-risk individuals — including non-smokers with genetic risk factors. Low-dose CT screening is recommended for high-risk individuals. Genetic counselling can help families with a history of lung cancer understand their inherited risk and implement appropriate monitoring.
FAQs
Can genetic testing predict lung cancer risk?
Genetic testing can identify inherited variants associated with elevated lung cancer susceptibility. This information, combined with environmental risk factors (smoking, air pollution exposure), allows for personalized risk assessment and targeted screening recommendations.
Why do non-smokers in India get lung cancer?
Non-smoker lung cancer in India is associated with indoor air pollution (biomass fuel combustion), outdoor air pollution, radon exposure, and genetic susceptibility. The higher frequency of EGFR mutations in Indian non-smoker lung cancer suggests a distinct biological pathway from smoking-related lung cancer.
Know Your Genetic Cancer Risk — Before Symptoms Appear
Genomepatri by MapmyGenome includes genetic risk assessment for lung cancer and 100+ other health conditions — backed by NABL-certified labs and expert genetic counsellors who help you build a personalised prevention and monitoring plan.
